Cargando…
Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
SIMPLE SUMMARY: Pancreatic cancer is a devastating disease with a poor survival rate, and oncogenic mutant KRAS is a major driver of its initiation and progression; however, effective strategies/drugs targeting major forms of mutant KRAS have not been forthcoming. Of note, obesity is known to worsen...
Autores principales: | Luo, Yongde, Li, Xiaokun, Ma, Jianjia, Abbruzzese, James L., Lu, Weiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918840/ https://www.ncbi.nlm.nih.gov/pubmed/33668583 http://dx.doi.org/10.3390/cancers13040778 |
Ejemplares similares
-
Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
por: Zhu, Liang, et al.
Publicado: (2022) -
Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
por: Wang, Dan, et al.
Publicado: (2019) -
The Significance of Mitochondrial Dysfunction in Cancer
por: Luo, Yongde, et al.
Publicado: (2020) -
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
por: Vallejo, Adrian, et al.
Publicado: (2017) -
Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)